4//SEC Filing
Stants Kristen 4
Accession 0000899243-22-027265
CIK 0001690585other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 9:11 PM ET
Size
9.0 KB
Accession
0000899243-22-027265
Insider Transaction Report
Form 4
Stants Kristen
Chief People Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-08-01+85,000→ 85,000 totalExercise: $1.57Exp: 2032-07-31→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022.
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001805727
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 9:11 PM ET
- Size
- 9.0 KB